These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 307576

  • 1. Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells.
    Herberman RB, Nunn ME, Holden HT.
    J Immunol; 1978 Jul; 121(1):304-9. PubMed ID: 307576
    [Abstract] [Full Text] [Related]

  • 2. Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
    Mattes MJ, Sharrow SO, Herberman RB, Holden HT.
    J Immunol; 1979 Dec; 123(6):2851-60. PubMed ID: 387876
    [Abstract] [Full Text] [Related]

  • 3. Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells.
    Nunn ME, Herberman RB.
    J Natl Cancer Inst; 1979 Apr; 62(4):765-71. PubMed ID: 285291
    [Abstract] [Full Text] [Related]

  • 4. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A, Herberman RB, Holden HT.
    J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
    [Abstract] [Full Text] [Related]

  • 5. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA, Macphail S, Bach FH, Zarling JM.
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD, Padmanabhan R, Lopez DM.
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [Abstract] [Full Text] [Related]

  • 7. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
    Santoni A, Piccoli M, Ortaldo JR, Mason L, Wiltrout RH, Herberman RB.
    J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
    [Abstract] [Full Text] [Related]

  • 8. Functional and binding activity of monoclonal anti-Thy-1 antibodies: evidence for different expression of the two alleles.
    Abehsira O, Edwards A, Simpson E.
    Eur J Immunol; 1981 Apr; 11(4):275-81. PubMed ID: 6788568
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC, Bonavida B.
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 11. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    Yang JC, Mulé JJ, Rosenberg SA.
    J Immunol; 1986 Jul 15; 137(2):715-22. PubMed ID: 2873187
    [Abstract] [Full Text] [Related]

  • 12. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression.
    Hurwitz JL, McAndrew EC, Doherty PC.
    J Immunol; 1986 Sep 15; 137(6):1757-63. PubMed ID: 2875109
    [Abstract] [Full Text] [Related]

  • 13. Functional Thy-1+ cells in cultures of spleen cells from nu/nu mice.
    Dennert G, Hyman R.
    Eur J Immunol; 1980 Aug 15; 10(8):583-9. PubMed ID: 6967413
    [Abstract] [Full Text] [Related]

  • 14. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV, Welsh RM, Haspel MV.
    J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198
    [Abstract] [Full Text] [Related]

  • 15. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr 15; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 16. A subpopulation of T cells bearing Fc receptors.
    Basten A, Miller JF, Warner NL, Abraham R, Chia E, Gamble J.
    J Immunol; 1975 Oct 15; 115(4):1159-65. PubMed ID: 1100723
    [Abstract] [Full Text] [Related]

  • 17. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 18. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
    Kiyohara T, Tanino T, Egawa K.
    Jpn J Exp Med; 1982 Aug 15; 52(4):201-8. PubMed ID: 7176145
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S, Naruo K, Shiho O, Tsukamoto K.
    Immunology; 1986 Oct 15; 59(2):251-9. PubMed ID: 3490435
    [Abstract] [Full Text] [Related]

  • 20. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK, Adler WH.
    J Immunol; 1979 Aug 15; 123(2):846-51. PubMed ID: 110883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.